Abstract
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer's disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have